Chitomur — EU research guide.
Chitomur is a Khavinson-series peptide bioregulator formulated from bladder tissue extract, proposed to support urothelial cell function. Unlike the synthetic tetrapeptides in the same family, it is a natural peptide complex (cytomedin) without one single defined amino acid sequence — closer in concept to Thymalin, which PeptideCompare already tracks, than to a synthetic compound like Epitalon.
What is Chitomur?
Chitomur is a Khavinson-series peptide bioregulator formulated from bladder tissue extract, proposed to support urothelial cell function. Unlike the synthetic tetrapeptides in the same family, it is a natural peptide complex (cytomedin) without one single defined amino acid sequence — closer in concept to Thymalin, which PeptideCompare already tracks, than to a synthetic compound like Epitalon.
What does the research show?
Published research is limited to small Eastern European cohort studies in urogenital aging contexts. No independently replicated controlled trials are publicly available as of mid-2026, and mechanism-of-action data is sparse compared with the synthetic short peptide bioregulators in the same series.
EU legal status
Not approved as a medicine anywhere in the EU. Available only from a small number of specialist Eastern European-linked research vendors.
Molecular information
Pharmacokinetics
Chitomur is not yet in our price comparison
We expand EU supplier coverage every month.